How specific is the immune response to malaria in adults living in endemic areas?

Journal of Vector Borne Diseases

Volumn 40, Issue 3-4, 2003, Pages 84-91

  Mannan, B A ^a   Patel, K ^a   Malhotra, I ^a   Ravindran, B ^b   Sharma, Shobhona ^a  

^a TATA INSTITUTE OF FUNDAMENTAL RESEARCH   (India)

^b REGIONAL MEDICAL RESEARCH CENTRE ICMR   (India)

Author keywords

Circulating malaria antibodies; Immunoclones; Immunopeptides; Malaria

Indexed keywords

COMPLEMENTARY DNA; IMMUNOGLOBULIN G; PEPTIDE;

AFRICA; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNE RESPONSE; IMMUNITY; INDIA; MALARIA; MOLECULAR CLONING; MYCOBACTERIOSIS; PASSIVE IMMUNIZATION; PLASMODIUM; PROTOZOAL GENETICS;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CHILD; ENDEMIC DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INDIA; KENYA; MALARIA, FALCIPARUM; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS;

EID: 1842418462     PISSN: 09729062     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Baird JK. Host age as a determinant of naturally acquired immunity to Plasmodium falciparum. Parasitol Today 1995; 11: 105-11.
2. Cohen S, McGregor IA, Carrington SP. Gammaglobulin and acquired immunity to human malaria. Nature 1961; 192: 733-7.
3. McGregor IA, Carrington SP, Cohen S. Treatment of east African P. falciparum malaria with west African human gamma-globulin. Trans R Soc Trop Med Hyg 1963; 57: 170-5.
4. Edozien JC, Gilles HM, Udeozo IOK. Adult and cord-blood gamma-globulin and immunity to malaria in Nigerians. Lancet 1962; ii: 951-5.
5. Bouharoun-Tayoun H, Oeuvray C, Lunel F, Druihle P. Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages. J Exp Med 1995; 182: 409-18.
6. Lobo CA, Kar SK, Ravindran B, Kabilan L, Sharma S. Novel proteins of Plasmodium falciparum identified by differntial immunoscreening using immune and patient sera. Infect Immun 1994; 62: 651-6.
7. Goswami A, Chatterjee S, Sharma S. Cloning of a ribsomal phosphoprotein PO gene homologus from P. falciparum. Mol Biochem Parasitol 1996; 82: 117-20.
8. Goswami A, Sharma S. A differential clone of Plasmodium falciparum shows homology to the yeast SEC65 domains. J Parasit Dis 1996; 20: 133-6.
9. Singh NJ, Sehgal A, Sharma S. Characterisation of a differential immunoscreen epitope of Plasmodium falciparum using combinational agents. Parasit Immunol 2000; 22: 333-40.
10. Goswami A, Singh S, Redkar VD, Sharma S. Characterisation of PO, a ribosomal phosphoprotein of Plasmodium falciparum. J Biol Chem 1997; 272: 12138-43.
11. Chatterjee S, Singh S, Sohoni R, Kattige V, Deshpande C, Chiplunkar S, Kumar N, Sharma S. Characterisation of domains of the phosphoriboprotein PO of Plasmodium falciparum. Mol Biochem Parasitol 2000; 107: 143-54.
12. Chatterjee S, Singh S, Sohoni R, Singh NJ, Vaidya A, Long C, Sharma S. Antibodies against ribosomal phosphoprotein PO of Plasmodium falciparum protect mice against challenge with Plasmodium yoelii. Infect Immun 2000; 68: 4312-8.
13. Singh S, Sehgal A, Waghmare S, Chakraborty T, Goswami A, Sharma S. Surface expression of the conserved ribosomal protein PO on parasite and other cells. Mol Biochem Parasitol 2005; 119: 121-4.
14. Singh S, Chatterjee S, Sohoni R, Badakare S, Sharma S. Sera from lupus patients inhibit growth of Plasmodium falciparum in culture. Autoimmunity 2001; 33: 253-63.
15. Koren E, Reichlin MW, Kosec M, Fugate RD, Reichlin M. Autoantibodies to the ribosomal P proteins react with a plasma membrane-related target on human cells. J Clin Invest 1992; 89: 1236-41.
16. Hirohata S, Nakanishi K. Antiribosomal P protein antibody in human systemic lupus erythematosus reacts specifically with activated T cells. Lupus 2001; 10: 612-21.
17. Thomas AW, Trape JF, Rogier C, Goncalves A, Rosario VE, Narum DL. High prevalence of natural antibodies against P. falciparum 83-kilodalton apical membrane antigen (Pf83/AMA-1) as detected by capture-enzyme-linked immunosorbent assay using full-length baculovirus recombinant Pf83/AMA-1. American J Trop Med Hyg, 1994; 51: 730-40.
18. Udhayakumar V, Kariuki S, Kolczack M, Girma M, Roberts JM, Oloo AJ, Nahlen BL, Lal AA. Longitudinal study of natural immune responses to the P. falciparum apical membrane antigen (AMA-1) in a holoendemic region of malaria in Western Kenya: a Asembo Bay Cohort Project VIII. American J Trop Med Hyg 2001; 65: 100-7.
19. Hodder AN, Crewther PE, Anders RF. Specificity of the protective antibody response to apical membrane antigen-1. Infect Immun 2001; 69: 3286-94.
20. Daniel-Ribeiro CT. Is there a role for autoimmunity in immune protection against malaria? Mem Inst Oswaldo Cruz 2000; 95: 199-207.
21. Perignon J, Druilhe P. Immune mechanisms underlying the premunition against Plasmodium falciparum malaria. Mem Inst Oswaldo Cruz 1994; 89: 51-3.
22. Pombo DJ, Lawrence G, Hirunpetcharat C, Rzepczyk C, Bryden M, Cloonan N, Anderson K, Mahakunkijcharoen Y, Martin LB, Wilson D, Elliott Salenna, Elliott Suzanne, Eisen DP, Weinberg JB, Saul A, Good MF. Immunity to malaria after administration of ultra-low dosage of red cells infected with Plasmodium falciparum. Lancet 2002; 360: 610-7.
23. Anders RF. Multiple cross-reactivities amongst antigens oT Plasmodium falciparum impair the development of protective immunity against malaria. Parasite Immunol 1986; 8: 529-39.